|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Maryland Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MarylandLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Greenebaum Cancer Center Cancer Center
| | | Phone: | (410) 328-7904 | Fax: | (410) 328-3018 | Year Established: | 1965 | Main Contact: | Kevin J. Cullen, M.D., Director | | Company Description | The University of Maryland Marlene and Stewart Greenebaum Cancer Center (UMGCC) has a long and rich history of cancer research, patient care and medical education throughout the state of Maryland and the Mid-Atlantic region. Located on the medical campus of the University of Maryland at Baltimore, the Center is part of both the University of Maryland Medical Center and the University of Maryland School of Medicine. All of the center's researchers and physicians are on the faculty of the medical school and other professional schools at the University of Maryland, Baltimore. The center was named in honor of real estate developer and businessman Stewart Greenebaum and his wife, Marlene, a breast cancer survivor.
The mission of the UMGCC is to undertake innovative basic and clinical research that will impact the understanding and treatment of cancer around the world and to provide state–of–the–art clinical care to cancer patients in Maryland and beyond. We conduct an interactive, multidisciplinary research program focusing on the rapid transfer of knowledge from the laboratory to the clinic. We have developed a national and international reputation as an institution with expertise in laboratory and clinical research providing new approaches to cancer treatment. Research performed at the UMGCC has had a significant impact on cancer care worldwide, particularly the pioneering work of Dr. Angela Brodie for the development of aromatase inhibitors for the treatment of breast cancer. | |
|
|
|
|
|